The US Food and Drug Administration (USFDA) concluded a GMP inspection of the company's API facility (Site 5), located at Visakhapatnam, Andhra Pradesh, on June 21, 2024, the company said in a regulatory filing
CNBC Awaaz
7 days ago
IBTmes India
Biocon Biologics gets EMA nod to manufacture cancer drug in India
5 days ago
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
The Economic Times
Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld | Pharma
MC Inside Edge: Operators gear up for second innings in GNFC, Biocon finds new believers, broker hardsells airport play
1 day ago
Financial Express
Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab at its new facility in Bengaluru
View all
An Indian biopharmaceutical company
biocon.com
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. Wikipedia
Stock price: BIOCON.BO (BSE) ₹351.00 +4.85 (+1.40%)
Fri, Jun 28, 2024, 6:00AM EDT